![]() |
市场调查报告书
商品编码
1422650
神经復健设备市场 - 按产品类型(神经机器人、穿戴式装置、BCI、非侵入性刺激器)、按应用(中风、多发性硬化症、帕金森氏症、脊髓损伤)、依最终用途(医院、专科诊所)和预测,2024 年-2032Neurorehabilitation Devices Market-By Product Type (Neurorobotics, Wearable Devices, BCI, Non-Invasive Stimulators), By Application (Stroke, MS, Parkinsons Disease, Spinal Cord Injury), By End-use (Hospitals, Specialty Clinics) & Forecast, 2024-2032 |
预计从 2024 年到 2032 年,神经復健设备市场规模将成长 13.4% 以上。神经系统疾病的盛行率不断上升,加上人口老化,正在推动对有效復健解决方案的需求。快速的技术进步,包括机器人辅助设备和基于虚拟实境的疗法,正在提高神经復健的功效。例如,2023年2月,数位神经治疗解决方案提供商MindMaze推出了Izar,这是首款针对手部运动功能受损患者的智慧週边,获得美国FDA批准并获得欧盟CE认证。欧洲联盟。
人们对神经系统疾病早期介入和復健益处的认识不断提高,这将推动神经復健设备的采用。此外,政府支持性措施的存在有利于个人化和家庭復健解决方案的整合。持续进行的专注于神经復健设备创新的研发活动将进一步推动产业成长。
神经復健设备市场按产品类型、应用、最终用途和地区划分。
根据产品类型,预计 2024 年至 2032 年可穿戴设备领域的行业份额复合CAGR为 13.7%。这一增长可归因于便携式和用户友好型神经復健解决方案的日益普及。穿戴式装置提供持续监测和个人化復健体验,以增强患者参与度。此外,将復健融入日常活动的便利性以及先进感测器技术的整合将推动产品需求。
由于脊髓损伤发生率不断上升,脊髓损伤应用领域的神经復健设备市场从 2024 年到 2032 年的CAGR可能达到 13%。先进的神经復健设备有助于功能恢復、肌肉强化和改善活动能力,进一步有助于提高脊髓损伤患者的復健效果。
从地区来看,亚太地区神经復健设备产业预计 2024 年至 2032 年间CAGR将达到13.7%。这种增长可归因于神经系统疾病盛行率的增加、人口老龄化的加剧以及对先进对復健解决方案的认识不断提高。此外,医疗保健基础设施的改善和技术先进的神经復健设备的日益采用将推动区域市场的扩张。
Neurorehabilitation devices market size is projected to expand at over 13.4% from 2024 to 2032. The increasing prevalence of neurological disorders coupled with the growing aging population is fueling the demand for effective rehabilitation solutions. The rapid technological advancements, including robotic-assisted devices and virtual reality-based therapies are leading to enhanced efficacy of neurorehabilitation. For instance, in February 2023, a provider of digital neuro-therapeutics solutions, MindMaze, launched Izar, a first-of-its-kind smart peripheral for patients with impaired hand motor function, approved by the U.S. FDA and CE-marked from the EU.
The rising awareness about the benefits of early intervention and rehabilitation in neurological conditions will drive the adoption of neurorehabilitation devices. Additionally, the presence of supportive government initiatives is favoring the integration of personalized and home-based rehabilitation solutions. The ongoing R&D activities, focusing on innovations in neurorehabilitation devices will further boost the industry growth.
The neurorehabilitation devices market is segregated into product type, application, end-use, and region.
Based on product type, the industry share from the wearable devices segment is projected to witness 13.7% CAGR from 2024 to 2032. The growth can be attributed to the increasing adoption of portable and user-friendly neurorehabilitation solutions. Wearable devices offer continuous monitoring and personalized rehabilitation experiences for enhancing patient engagement. Moreover, the convenience of incorporating rehabilitation into daily activities and the integration of advanced sensor technologies will fuel the product demand.
Neurorehabilitation devices market from the spinal cord injury application segment may strike a 13% CAGR from 2024 to 2032, owing to the rising incidences of spinal cord injuries. Advanced neurorehabilitation devices help in functional recovery, muscle strengthening, and improving mobility, further contributing to enhanced rehabilitation outcomes for individuals with spinal cord injuries.
Regionally, the Asia Pacific neurorehabilitation devices industry is projected to expand at 13.7% CAGR between 2024 and 2032. The growth can be ascribed to the increasing prevalence of neurological disorders, growing aging population, and rising awareness about advanced rehabilitation solutions. Furthermore, the improvements in healthcare infrastructure and the increasing adoption of technologically advanced neurorehabilitation devices will drive the regional market expansion.